DeepLook
New Haven, US · Founded 2018 · 4 known investors
DeepLook Medical develops DL Precise, an image-enhancement technology that improves visualization of soft tissue lesions in mammograms to help radiologists interpret images more clearly and reduce unnecessary follow-up screenings. It serves healthcare providers, payers, and patients in breast cancer imaging in the US.
Founders & leadership
MF
Marissa FayerExecutive Officer, Director
DD
David DahnExecutive Officer
GB
Gregory BelangerExecutive Officer, Director
SS
Steve SchwadronExecutive Officer, Director
KB
Ken BoulangeExecutive Officer, Director
KG
Karim GalzahrDirector
MS
Michael ShufeldtDirector
Investors · 4
Reported raises · per SEC filings
Form D private placements▶$2.5MraisedSep 2024 · 26 investors · Other TechnologyRule 506(b)
▶$2.5MraisedSep 2024 · 26 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- David DahnExecutive Officer
- Marissa FayerExecutive Officer, Director
- Karim GalzahrDirector
- Michael ShufeldtDirector
- Offering amount
- $6.9M
- Amount sold
- $2.5M
- First sale
- Sep 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.5MraisedJan 2023 · 37 investors · Other Health CareRule 506(b)
▶$1.5MraisedJan 2023 · 37 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Marissa FayerExecutive Officer, Director
- David DahnExecutive Officer
- Gregory BelangerExecutive Officer, Director
- Steve SchwadronExecutive Officer, Director
- Ken BoulangeExecutive Officer, Director
- Offering amount
- $1.5M
- Amount sold
- $1.5M
- First sale
- Jan 2023
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.